Exosomes-Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth.
Fan L, Liu C, Chen X, Zheng L, Zou Y, Wen H, Guan P, Lu F, Luo Y, Tan G, Yu P, Chen D, Deng C, Sun Y, Zhou L, Ning C. · 2022
Read Exosomes-Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth. by Fan L, Liu C, Chen X, Zheng L, Zou Y, Wen H, Guan P, Lu F, Luo Y, Tan G, Yu P, Chen D, Deng C, Sun Y, Zhou L, Ning C. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9069372.txt.
Introduction
Fan and co-authors built a conductive hydrogel loaded with stem-cell exosomes to repair spinal cord injury. Conductive gels match the cord's softness and electrical nature, but can stir inflammation on their own. The team filled the gel with exosomes from bone marrow stem cells, which calm immune cells and aid regrowth. In lab tests, the gel steered microglia toward their healing state.
It also pushed stem cells to become neurons and insulation cells, and lengthened growing axons. In injured mice, the implant cut inflammation, drew in local stem cells, and restored movement early. The authors call the pairing a promising repair strategy.
Catalog record
| CREATOR | Fan L, Liu C, Chen X, Zheng L, Zou Y, Wen H, Guan P, Lu F, Luo Y, Tan G, Yu P, Chen D, Deng C, Sun Y, Zhou L, Ning C. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Exosomes‐Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth By Lei Fan, Can Liu, Xiuxing Chen, Lei Zheng, Yan Zou, Huiquan Wen, Pengfei Guan, Fang Lu, Yian Luo, Guoxin Tan, Peng Yu, Dafu Chen Published in: Advanced Science DOI: 10.1002/advs.202105586 ABSTRACT Abstract Electroconductive hydrogels are very attractive candidates for accelerated spinal cord injury (SCI) repair because they match the electrical and mechanical properties of neural tissue. However, electroconductive hydrogel implantation can potentially aggravate inflammation, and hinder its repair efficacy. Bone marrow stem cell‐derived exosomes (BMSC‐exosomes) have shown immunomodulatory and tissue regeneration effects, therefore, neural tissue‐like electroconductive hydrogels loaded with BMSC‐exosomes are developed for the synergistic treatment of SCI. These exosomes‐loaded electroconductive hydrogels modulate microglial M2 polarization via the NF‐κB pathway, and synergistically enhance neuronal and oligodendrocyte differentiation of neural stem cells (NSCs) while inhibiting astrocyte differentiation, and also increase axon outgrowth via the PTEN/PI3K/AKT/mTOR pathway. Furthermore, exosomes combined electroconductive hydrogels significantly decrease the number of CD68‐positive microglia, enhance local NSCs recruitment, and promote neuronal and axonal regeneration, resulting in significant functional recovery at the early stage in an SCI mouse model. Hence, the findings of this study demonstrate that the combination of electroconductive hydrogels and BMSC‐exosomes is a promising therapeutic strategy for SCI repair. Keywords: anti‐inflammation, axonal regeneration, BMSC‐derived exosomes, electroconductive hydrogels, spinal cord injury INTRODUCTION An estimated 27 million people live with long‐term disability following spinal cord injury (SCI) worldwide, with ≈180 000 new cases occurring each year.[ 1 ] SCI is followed by neuronal loss and axon and myelin necrosis, which leads to an extensive inflammatory response and further exacerbates secondary damage.[ 2 ] Meanwhile, activated inflammatory cells (microglia) release proinflammatory cytokines, which contribute to reactive astrocyte gathering, subsequently increasing the release of inhibitory molecules such as chondroitin sulfate proteoglycans (CSPGs) at the injury site.[ 3 ] Because of the inflammatory microenvironment and limited neural regeneration capacity, the injury is resolved by the formation of a dense glial scar, which acts as a barrier to neural and axonal regeneration.[ 4 ] Thus, modulation of the inflammatory microenvironment, enhancement of neural stem cell (NSCs) recruitment and neuronal regeneration, and guidance and promotion of myelinated axon growth are needed for treating spinal cord injury (SCI). Decompressive surgery with re‐establishment of spinal stability and high‐dose intravenous methylprednisolone sodium succinate (MPSS) usage in the acute phase of injury (≤8 h) are the most common clinical treatments at present.[ 5 ] However, the former only aims to avoid further secondary damage by relieving the pressure on the injured spinal cord, and the latter can reduce early inflammatory responses but with severe complications, while neither show the ability to promote axonal and neural regeneration and therefore, have limited therapeutic effectiveness. In this regard, experimental approaches to promote axon growth including cellular transplantation and scaffold biomaterials have been applied in SCI repair.[ 6 ] Cellular transplantation has been used experimentally in clinical conditions with some success but continues to be limited by uncontrolled cell differentiation, low survival rates, ethical issues, and the inevitable cell loss after implantation.[ 7 ] Considering the seriousness of these problems, cost‐effective and cell‐free biomaterial implants are highly desirable. Scaffold biomaterial‐based therapy with tunable modulus, topology, patterned surfaces has been proposed as a strategy to promote neural tissue regeneration by providing 3D matrices with the desired biological, chemical, and physical characteristics that favor cellular attachment, growth, differentiation, and neurite extension.[ 8 , 9 ] In particular, since the soft and hydrated forms of hydrogels are similar to native nerve tissue, they are widely used to promote cellular growth and tissue formation after SCI.[ 10 , 11 ] Our previous study revealed that the mechanical properties of the hydrogel could modulate the fates of NSCs which are sensitive to mechanical changes. NSCs were inclined to differentiate into neurons and lengthen axons in soft scaffolds; otherwise, NSCs are prone to differentiate into astrocyte in slightly stiffer materials.[ 12 , 13 ] However, hydrogels with poor conductivity limit their application in regulating the function of excitable cell types such as muscle and nerve cells.[ 11 ] Importantly, mimicking the electrical transmission properties of the native nerve tissue is highly beneficial for SCI repair. Currently, electroconductive hydrogels have emerged as a promising class of hydrogel scaffolds combining a hydrophilic matrix with conducting components such as electroconductive polymers, metallic nanoparticles, or carbon materials.[ 12 ] Due to its tissue‐like softness and the inherent presence of electrical fields similar to the innate nervous system, the electroconductive hydrogel can provide mechanical and electrical cues for enhancing neuronal differentiation of NSCs and controlling neurite extension.[ 11 , 13 ] We previously developed a porous, highly electroconductive, soft, and biocompatible conducting polymer hydrogel, which forms a freestanding electroconductive hydrogel for implantation into the spinal cord hemisection gap, and recently demonstrated that implanting this electroconductive hydrogel after SCI stimulated endogenous NSCs recruitment and neuronal differentiation after SCI.[ 14 , 15 , 16 ] Although electroconductive hydrogels effectively enhanced neuronal and axonal regeneration, their efficacy is compromised by host recognition and the subsequent foreign body immune responses, which cannot attenuate or even aggravate the early secondary inflammation after acute SCI.[ 17 , 18 ] Thus, single transplantation of electroconductive hydrogel may not be sufficient to achieve a substantial improvement in SCI repair. Bone marrow stem cell (BMSC) therapy shows characteristic immunomodulatory effects and has been applied in severe clinical inflammatory diseases such as pancreatitis, colitis, and focal cerebral ischemia.[ 15 ] Exosomes are involved in intercellular communication and act on the innate immune system as paracrine messengers. They also exert immunomodulatory effects and can alleviate immune abnormalities.[ 19 , 20 ] Recently, BMSC‐exosomes have emerged as a new cell‐free therapeutic platform for various diseases due to their therapeutic effects, including their ability to promote regeneration and modulate immunoreaction.[ 21 ] BMSC‐exosomes, as a promising nanocarriers, carry various therapeutic growth factors and miRNAs, leading to axonal regeneration and angiogenesis enhancement, structural and electrophysiological improvements, and neuroinflammation and gliosis reduction, resulting in significant motor improvement and sensory recovery after spinal cord injury.[ 21 , 22 ] Meanwhile, neuroinflammation reduction caused by miRNAs contained in BMSC‐exosomes can negatively regulate the TLR4/NF‐κB pathway.[ 23 , 24 ] Delivery of immune‐modulating BMSC‐exosomes in electroconductive hydrogel can attenuate adverse host immune response and exert synergistically therapeutic effects in combination with electroconductive hydrogel to promote functional recovery. However, exosome‐loaded electroconductive hydrogel systems have not been investigated for their ability to promote tissue repair. In view of this, we hypothesized that an electroconductive hydrogel combined with BMSC‐exosomes might achieve adequate therapeutic effectiveness in patients with SCI. Moreover, the delivery of BMSC‐exosomes in electroconductive hydrogels can attenuate adverse host immune effects while synergistically exerting the therapeutic effect of promoting neuronal and axonal regeneration, thereby alleviating SCI. Herein, we developed exosome‐loaded dual‐network electroconductive hydrogels composed of photo‐cross‐linkable gelatin methacrylate (GM) hydrogels and polypyrrole (PPy) hydrogels. First, the GM/PPy (GMP) hydrogel scaffold was fabricated by in situ growth of the PPy network cross‐linked and doped by tannic acid (TA) within the GM hydrogel networks, which possesses natural cell binding motifs such as Arg–Gly–Asp (RGD), allowing cells to grow within it. Then, BMSC‐exosomes were immobilized in the TA‐doped GMP hydrogel network to form a